Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults

Dongming Chen; Jun Dong; Ying Huang; Feng Gao; Xiaopeng Yang; Xianglun Gong; Xiaochen Lv; Chenghao Chu; Yonggang Wu; Yong Zheng

doi:10.18632/oncotarget.18986

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults

Dongming Chen, Jun Dong, Ying Huang, Feng Gao, Xiaopeng Yang, Xianglun Gong, Xiaochen Lv, Chenghao Chu, Yonggang Wu and Yong Zheng _

PDF | HTML | How to cite

Oncotarget. 2017; 8:57265-57277. https://doi.org/10.18632/oncotarget.18986

Metrics: PDF 1310 views | HTML 2279 views | ?

Abstract

Dongming Chen1,*, Jun Dong1,*, Ying Huang2,*, Feng Gao1, Xiaopeng Yang1, Xianglun Gong1, Xiaochen Lv3, Chenghao Chu4, Yonggang Wu1 and Yong Zheng5

1Neurosurgery Department, People’s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi 830001, Xinjiang, China

2Respiratory Department, People’s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi 830001, Xinjiang, China

3Nursing College of Xinjiang Medical University, Urumqi 830001, Xinjiang, China

4Tumor Hospital of Xinjiang Medical University, Urumqi 830001, Xinjiang, China

5Neurosurgery Department, The Eighth People’s Hospital of Shenzhen, Shenzhen 518101, Guangdong, China

*These authors have contributed equally to this work

Correspondence to:

Yong Zheng, email: [email protected]

Yonggang Wu, email: [email protected]

Keywords: glioma, meningioma, MTHFR, MTRR, SNP: meta-analysis

Received: November 15, 2016 Accepted: June 01, 2017 Published: July 04, 2017

ABSTRACT

Polymorphic variants of genes involved in folate metabolism are implicated in the susceptibility to meningioma and glioma, but the results from published articles are controversial and inconclusive. Therefore, we performed this meta-analysis including all studies available to evaluate the relationship between folate metabolism genetic polymorphisms and the susceptibility to meningioma and glioma in adults. We searched the literature in PubMed, EMBASE and Cochrane Central Library for relevant articles published up to August 2016. The odds ratios (ORs) and the corresponding 95% confidence intervals (95%Cls) were used to evaluate the associations of two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) with the risk of meningioma and glioma in adults. We found significant association of MTHFR A1298C (rs1801131) variant genotypes with increased incidence of meningioma and glioma in this study population (CA vs. AA: OR=1.22, P<0.001; CA+CC vs. AA: OR=1.18, P=0.002). Moreover, we found that MTRR A66G (rs1801394) variant genotypes was associated with increased risk of meningioma and glioma (G vs. A: OR=1.11, P=0.020; GG vs. AA+AG: OR=1.17, P=0.043; GG vs. AA: OR=1.22, P=0.023). In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18986

Publication Alerts

Research Papers:

Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults

Abstract